Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE3733.35-2.55 (-0.07 %)
PREV CLOSE () 3735.90
OPEN PRICE () 3734.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7260
TODAY'S LOW / HIGH ()3721.95 3773.55
52 WK LOW / HIGH ()2730 3949
NSE3734.35-0.1 (0 %)
PREV CLOSE() 3734.45
OPEN PRICE () 3734.45
BID PRICE (QTY) 3734.35 (31)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 281509
TODAY'S LOW / HIGH() 3724.00 3772.90
52 WK LOW / HIGH ()2730 3934.7
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990

Management Info :

Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director

Registered Office :

Address : 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone : 040 66966300

Website : www.divislabs.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
16Nov Divi’s Laboratories informs about disc
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..
06Nov Divi's Laboratories reports 29% fall i
Divi's Laboratories has reported results for second quarter ended Septem..
06Nov Divi's Laboratories informs about outc
Divi's Laboratories has informed that the Board of Directors of the Comp..
06Nov Divi's Laboratories informs about outc
Divi's Laboratories has informed that the Board of Directors of the Comp..
06Nov Divi's Laboratories shines despite rep
Divi's Laboratories is currently trading at Rs. 3514.80, up by 164.90 po..
Financials
in Millions
QTR Sep 23 ANNUAL 23
Net Profit342018081.5
Gross Profit 4640 23541
Operating Profit 559026966.9
Net Sales 1868076253
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Alkem Laboratories (BSE)
 4884.60 (3.27%)
M.Cap ( in Cr)
58402.72
Dr. Reddy's Lab (BSE)
 5784.05 (0.98%)
M.Cap ( in Cr)
96478.08
Astrazeneca Pharma I (BSE)
 4855.10 (0.95%)
M.Cap ( in Cr)
12137.75
Mankind Pharma (BSE)
 1997.90 (2.33%)
M.Cap ( in Cr)
80033.56
TTK Healthcare (BSE)
 1389.95 (3.27%)
M.Cap ( in Cr)
1964.05
Shareholding Pattern
PROMOTERS 51.93%
MUTUAL FUNDS/UTI 13.62%
NON-INSTITUTION 11.73%
FI/BANKS/INSURANCE 7.35%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX69521.69-132.04 (-0.19%)
NIFTY20901.15-36.55 (-0.17%)
Dow Jones 36054.43-70.13 (-0.19%)
Nasdaq 14146.71-83.20 (-0.58%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.